Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Astellas Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

23 Jul 2016 Reuters Investment Profile 12 $20.00

Wright Investors Service Comprehensive Report for Astellas Pharma Incorporated

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

27 Jul 2016 Wright Reports 61 $75.00

Thomson Reuters Stock Report - Astellas Pharma Inc (4503-TO)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 Jul 2016 Thomson Reuters Stock Report 11 $25.00

"The Economy Matters" Report for ALPMF: the economy's impact on ALPMF's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

26 Jul 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

"The Economy Matters" Report for ALPMY: the economy's impact on ALPMY's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

26 Jul 2016 MacroRisk Analytics/EconomicInvestor 8 $25.00

ASTELLAS PHARMA INC (ALPMY=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

23 Jul 2016 Pechala's Reports 2 $25.00

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review Summary Astellas Pharma Inc. (Astellas) is one of ...

08 Jul 2016 GlobalData 345 $300.00

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review

Astellas Pharma Inc. (4503) - Financial and Strategic SWOT Analysis Review Summary Astellas Pharma Inc. (Astellas) is one of ...

09 Jun 2016 GlobalData 321 $300.00

ValuEngine Rating and Forecast Report for ALPMY

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

05 Jun 2016 ValuEngine, Inc. 11 $25.00

Astellas Pharma Inc.

MarketLine's Astellas Pharma Inc. Company Profile is the essential source for top-level company data and information. The re...

27 May 2016 MarketLine 30 $50.00